Securities code: 600227 securities abbreviation: shengjitang No.: 2022-006 Guizhou Salvage Pharmaceutical Co.Ltd(600227)
Announcement on correction of annual performance loss in 2021
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Due to the negligence of the staff, Guizhou Salvage Pharmaceutical Co.Ltd(600227) (hereinafter referred to as “the company”) disclosed the wrong content (time) of the announcement of Guizhou Salvage Pharmaceutical Co.Ltd(600227) 2021 annual performance advance loss (Announcement No.: 2022-003) on January 29, 2022, which is hereby corrected as follows:
Before correction:
4、 Risk tips
(II) the company has communicated with the annual audit accountant on the above uncertain factors, and the determination of the net realizable value of inventory involves significant management judgment. The sales price in January 2021 is temporarily used as a reference.
After correction:
4、 Risk tips
(II) the company has communicated with the annual audit accountant on the above uncertain factors, and the determination of the net realizable value of inventory involves significant management judgment. The sales price in January 2022 is temporarily taken as a reference.
In addition to the above corrections, other contents of Guizhou Salvage Pharmaceutical Co.Ltd(600227) 2021 annual performance pre loss announcement remain unchanged.
The Company Apologizes for the inconvenience caused to investors by the above correction. Please understand.
It is hereby announced
Guizhou Salvage Pharmaceutical Co.Ltd(600227) board of directors February 7, 2002
